rC19 (dose 1)

BIOLOGICAL2 trials

Sponsors

Sanofi

Conditions

COVID-19 ImmunizationInfluenza Immunization

Phase 1

Study of a Combination Vaccine Comprised of Different Recombinant Spike Antigen Levels of a Matrix-M Adjuvanted Recombinant COVID-19 Vaccine and Recombinant Influenza Vaccine in Adult Participants 50 Years of Age and Older

Active, not recruitingNCT06695130

SanofiCOVID-19 Immunization, Influenza Immunization

Start: 2024-11-18End: 2026-04-03Updated: 2025-05-28

Study of a Combination Vaccine Comprised of Different Recombinant Spike Antigen Levels of a Matrix-M Adjuvanted Recombinant COVID-19 Vaccine and High-Dose Inactivated Influenza Vaccine in Adult Participants 50 Years of Age and Older

Active, not recruitingNCT06695117

SanofiCOVID-19 Immunization, Influenza Immunization

Start: 2024-11-19End: 2026-04-01Updated: 2025-04-01